European Union Expands Kalydeco’s Approval to Certain CF Patients Ages 1-2
Kalydeco (ivacaftor) by Vertex Pharmaceuticals has been approved in the European Union for children ages 1-2 with cystic fibrosis (CF)...
Cystic Fibrosis Patients Exposed to Higher Risks of Liver Cancer
Researchers from Colorado, in the United States, shared the results of a study that showed that patients with cystic fibrosis would be at...
New Mucus Study Could Hold the Key to Clearing Your Phlegm
Mucus, you fickle fiend—usually, you’re there keeping us safe from whatever nasties sneak inside of us. But then you turn, becoming a...
